NBP
NovaBridge Biosciences
1.40$
+1.8%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q1 20 | Q2 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q3 22 | Q1 23 | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | – | 100.0% | 100.0% | – | – | – | – | 100.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | 66.1% | 66.1% | 52.5% | – | 277.1% | – | – | – | – | – | – | – | – | 0.1% | – | – | – | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -5,462.0% | – | 100.0% | 100.0% | 100.0% | 33.9% | 33.9% | 47.5% | – | 100.0% | 100.0% | – | -1,687.5% | 100.0% | – | – | – | – | 100.0% | – | – | – | – | |
| 948.2% | 948.2% | 508.2% | 1,072.7% | 1,767.2% | 1,767.2% | 2,088.6% | 288,799.7% | – | 3,549.6% | 3,335.9% | 3,335.9% | 882.5% | 882.5% | 872.8% | – | 2,271.2% | 2,271.4% | – | 3,429.8% | 152.8% | – | – | – | – | 1.3% | – | – | – | – | |
| 87.4% | 87.4% | 101.0% | 245.2% | 3,830.6% | 3,830.6% | 54.3% | 111,907.4% | – | 1,931.5% | 2,489.3% | 2,489.3% | 638.3% | 638.3% | 756.8% | – | 1,246.4% | 1,246.5% | – | 4,549.8% | 121.1% | – | – | – | – | 2.4% | – | – | – | – | |
| 1,171.9% | 1,171.9% | 609.2% | 1,608.5% | 5,694.0% | 5,694.0% | 2,142.9% | 757,046.1% | – | 5,481.1% | 5,875.9% | 5,875.9% | 1,520.8% | 1,520.8% | 1,629.6% | – | 3,517.6% | 3,517.8% | – | 7,979.7% | 273.9% | – | – | – | – | 3.8% | – | – | – | – | |
| -1,095.7% | -1,095.7% | -586.9% | -1,382.6% | -5,497.8% | -5,497.8% | -2,042.9% | -400,707.2% | – | -5,381.1% | -5,775.9% | -5,775.9% | -1,486.9% | -1,486.9% | -1,582.1% | – | -3,417.6% | -3,417.8% | – | -7,979.7% | -173.9% | – | – | – | – | -3.8% | – | – | – | – | |
| – | – | 6.8% | 1.6% | – | – | 0.5% | 97.3% | – | 0.1% | 0.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -926.3% | -926.3% | -575.4% | -1,338.1% | -5,715.6% | -5,715.6% | -1,640.3% | -380,581.5% | – | -1,371.7% | -8,926.4% | -8,926.4% | -2,280.5% | -2,280.5% | 3,895.4% | – | -3,931.6% | -3,931.8% | – | -6,162.2% | -81.5% | – | – | – | – | -2.9% | – | – | – | – | |
| – | – | 7.4% | 0.8% | – | – | – | – | – | -1,541.0% | -2,870.6% | -2,870.6% | -494.0% | -494.0% | 5,914.0% | – | 0.0% | – | – | – | 9.3% | – | – | – | – | -161.5% | – | – | – | – | |
| -779.9% | -779.9% | -511.7% | -1,188.3% | -5,715.6% | -5,715.6% | -1,640.3% | -380,581.5% | – | 169.3% | -6,055.8% | -6,055.8% | -1,786.5% | -1,786.5% | -2,018.7% | – | -3,931.6% | -3,931.8% | – | 1,835.2% | -46.1% | – | – | – | – | -2.9% | – | – | – | – | |
| -929.2% | -929.2% | -504.5% | -1,176.2% | -5,468.1% | -5,468.1% | -186.4% | -397,382.3% | – | -5,344.4% | -5,687.4% | -5,687.4% | -1,475.8% | -1,475.8% | -1,558.6% | – | -1,269.9% | 3,295.2% | – | -7,452.5% | -165.5% | – | – | – | – | -3.7% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.